These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients. Rieger CT; Ostermann H; Kolb HJ; Fiegl M; Huppmann S; Morgenstern N; Tischer J Ann Hematol; 2008 Nov; 87(11):915-22. PubMed ID: 18641986 [TBL] [Abstract][Full Text] [Related]
47. Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation. Girmenia C; Ferretti A; Barberi W Curr Opin Hematol; 2014 Nov; 21(6):459-65. PubMed ID: 25295743 [TBL] [Abstract][Full Text] [Related]
48. Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity. Christopeit M; Eikam M; Behre G Mycoses; 2008; 51 Suppl 1():19-24. PubMed ID: 18471157 [TBL] [Abstract][Full Text] [Related]
49. [Therapy of severe fungal infections]. Battegay M; Flückiger U Internist (Berl); 2003 Dec; 44(12):1549-56. PubMed ID: 14689198 [TBL] [Abstract][Full Text] [Related]
50. Optimal use of the newer antifungal agents. Helwick C Oncology (Williston Park); 2000 Sep; 14(9):1262-4. PubMed ID: 11033823 [No Abstract] [Full Text] [Related]
51. New facets of antifungal therapy. Chang YL; Yu SJ; Heitman J; Wellington M; Chen YL Virulence; 2017 Feb; 8(2):222-236. PubMed ID: 27820668 [TBL] [Abstract][Full Text] [Related]
53. Clinically relevant drug-drug interactions between antiretrovirals and antifungals. Vadlapatla RK; Patel M; Paturi DK; Pal D; Mitra AK Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):561-80. PubMed ID: 24521092 [TBL] [Abstract][Full Text] [Related]
54. Candida Parapsilosis in peripheral blood. Arora N; Parihar M; Mishra D; Bhattacharya S; Chakrapani A Indian J Pathol Microbiol; 2014; 57(4):645. PubMed ID: 25308031 [No Abstract] [Full Text] [Related]
55. Current concepts in antifungal pharmacology. Lewis RE Mayo Clin Proc; 2011 Aug; 86(8):805-17. PubMed ID: 21803962 [TBL] [Abstract][Full Text] [Related]
56. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients. Singh N; Heitman J Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015 [TBL] [Abstract][Full Text] [Related]
57. [Clinical usefulness of triazole derivatives in the management of fungal infections]. Carrillo-Muñoz AJ; Giusiano G; Arechavala A; Tur-Tur C; Eraso E; Jauregizar N; Quindós G; Negroni R Rev Esp Quimioter; 2015 Aug; 28(4):169-82. PubMed ID: 26200025 [TBL] [Abstract][Full Text] [Related]
58. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Nett JE; Andes DR Infect Dis Clin North Am; 2016 Mar; 30(1):51-83. PubMed ID: 26739608 [TBL] [Abstract][Full Text] [Related]
59. Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions. Tragiannidis A; Gkampeta A; Vousvouki M; Vasileiou E; Groll AH Expert Opin Drug Saf; 2021 Sep; 20(9):1061-1074. PubMed ID: 33896310 [TBL] [Abstract][Full Text] [Related]